Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer
β Scribed by Mitsugu Kochi; Masashi Fujii; Noriaki Kanamori; Teruo Kaiga; Tetsuya Kawakami; Kazuo Aizaki; Mitsuko Kasahara; Fumiro Mochizuki; Yuichi Kasakura; Motoo Yamagata
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 156 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1436-3291
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CA19-9 is a specific tumor marker in patients with gastrointestinal cancer; however, some patients with respiratory disease can have elevated serum levels of CA19-9 as well. In this study we evaluated serum CA19-9 levels of patients with nonmalignant respiratory diseases. We also estimated the progn
The antibody against CA-195 binds to an epitope that consists of both Lewis A and sialylated Lewis A blood group antigen, whereas CA19-9 has shown specificity for sialylated Lewis A blood group antigen. CA19-9 and CA-195 levels were measured in the sera of 52 normal subjects; 65 benign disease patie
Background. Interleukin-6 (IL-6) is a multifunctional cytokine that can be produced by human ovarian cancer cells. Elevated IL-6 levels have been found in the serum and ascites of patients with ovarian cancer, but its role in this disease has not been clearly established. Methods. The authors studi